VivaBioCell. Delivering next-generation manufacturing solutions for sustainable cell therapies
Certainly, VivaBioCell means innovation.
Thanks to our unique and diversified expertise we are able to provide new tools overcoming the current state-of-the-art in cell culturing and advanced therapy manufacturing.
NANT XL System
The evolution of automated cell expansion systems for mid- up to large-scale batch sizes. Maximum flexibility in cell expansion for clinical and commercial Advanced Therapies manufacturing needs. Learn more >
NANT 001 System
Seamless transition from R&D to clinical and commercial manufacturing. Automated cell expansion and harvest. Small- to mid-scale batch sizes. Assuring product quality and minimizing costs. Easier cGMP translation and shorter time to market. Ideal for autologous products and redistributed scale-out manufacturing. Learn more >
Latest News
Validation of the NANT 001 Bioreactor System for automated adipose-derived MSCs expansion
The results just published by The Regenerative Medicine Institute (REMEDI, Galway, Ireland) show how the NANT 001 System is able to effectively expand autologous MSCs derived from adipose tissue, in aseptic conditions and with a standardized automated process. Read more ›
See You in September!
Due to the current COVID-19 outbreak both Advanced Therapies Congress & Expo and 19th ESSKA Congress will be postponed in September 2020. Read more ›
VivaBioCell is proud to be attending the event "Meet in Italy for Life Sciences 2019" in Trieste next 16-19th October
Come visit us at our booth and make sure to join our workshop taking place on 17th October at 9:30 (Sala 3) where we will shed lights on the A.R.T.E. Project (Advanced Regenerative Therapies Ecosystem). Read more ›
© 2020 VivaBioCell S.p.A. a socio unico
via del Cotonificio, 127 - 33100 - Udine, Italy
P. IVA 02470470309 - R.E.A. UD-263358
Capitale sociale € 981.974,00 i.v.
Privacy Policy
